ResMed (RMD) shares rallied 4.2% in the last trading session to close at $218.4. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 6.9% gain over the past four weeks.ResMed scored a strong price increase on investors’ optimism surrounding the company’s impending fourth quarter fiscal 2026 financial results, which is expected to release on August 6, 2026. Per the Zacks Consensus Estimate, the company’s revenues ...